Oak Thistle LLC bought a new position in shares of Revvity Inc. (NYSE:RVTY - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 14,388 shares of the company's stock, valued at approximately $1,392,000.
Other hedge funds have also recently modified their holdings of the company. CYBER HORNET ETFs LLC bought a new position in shares of Revvity during the 2nd quarter worth approximately $32,000. Cromwell Holdings LLC increased its stake in shares of Revvity by 141.4% during the 4th quarter. Cromwell Holdings LLC now owns 338 shares of the company's stock worth $33,000 after purchasing an additional 198 shares during the last quarter. MUFG Securities EMEA plc purchased a new stake in shares of Revvity during the 2nd quarter worth approximately $34,000. Headlands Technologies LLC purchased a new stake in shares of Revvity during the 2nd quarter worth approximately $49,000. Finally, Smartleaf Asset Management LLC increased its stake in shares of Revvity by 56.8% during the 3rd quarter. Smartleaf Asset Management LLC now owns 690 shares of the company's stock worth $58,000 after purchasing an additional 250 shares during the last quarter. Institutional investors own 86.65% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts have recently issued reports on the stock. Bank of America lowered shares of Revvity from a "buy" rating to a "neutral" rating and set a $110.00 price target for the company. in a research note on Monday, December 15th. TD Cowen restated a "hold" rating on shares of Revvity in a research note on Tuesday, February 3rd. Weiss Ratings lowered shares of Revvity from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Wednesday, March 18th. Jefferies Financial Group raised their price target on shares of Revvity from $100.00 to $105.00 and gave the stock a "hold" rating in a research note on Monday, February 2nd. Finally, Evercore raised their price target on shares of Revvity from $112.00 to $118.00 and gave the stock an "outperform" rating in a research note on Tuesday, February 3rd. Five investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Revvity presently has a consensus rating of "Hold" and a consensus target price of $112.92.
Get Our Latest Stock Analysis on Revvity
Revvity Stock Up 0.2%
Revvity stock opened at $90.57 on Friday. Revvity Inc. has a 1-year low of $81.36 and a 1-year high of $118.30. The firm has a market capitalization of $10.13 billion, a price-to-earnings ratio of 43.54, a P/E/G ratio of 1.92 and a beta of 1.13. The company has a current ratio of 1.68, a quick ratio of 1.40 and a debt-to-equity ratio of 0.36. The firm has a 50 day simple moving average of $93.59 and a 200 day simple moving average of $96.61.
Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings data on Monday, February 2nd. The company reported $1.70 earnings per share for the quarter, beating analysts' consensus estimates of $1.55 by $0.15. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The business had revenue of $772.06 million during the quarter, compared to analyst estimates of $759.81 million. During the same period in the previous year, the business earned $1.42 EPS. Revvity's revenue was up 5.9% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. On average, analysts predict that Revvity Inc. will post 4.94 earnings per share for the current year.
Revvity Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Friday, April 17th will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Friday, April 17th. Revvity's payout ratio is currently 13.46%.
About Revvity
(
Free Report)
Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.
Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.
Further Reading
Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity Inc. (NYSE:RVTY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Revvity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.
While Revvity currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.